Dr. Drew Weissman Awarded Nobel Prize in Physiology or Medicine
The CIVICs Network is thrilled to congratulate Dr. Drew Weissman, an investigator who is part of the Duke CIVIC Vaccine Center, on winning the 2023
October 23, 2023
News Items
CIVICs Research Towards a Universal Influenza Vaccine Featured by NIH
Coronaviruses and influenza viruses pose a major risk to global health, underscored by the impact of the COVID-19 pandemic and continuing spread of SARS-CoV-2 variants.
August 24, 2023
Recap of the Duke CIVICs Vaccine Center (DCVC) Annual Retreat
The Duke CIVIC Vaccine Center (DCVC) hosted a hybrid annual retreat on May 4 and 5, the second retreat since the contract’s inception in September
June 27, 2023
NIAID Announces Clinical Trial for mRNA Universal Influenza Vaccine at the Duke CIVICs Clinical Core
The National Institute of Allergy and Infectious Diseases (NIAID) announced that the Duke Human Vaccine Institute (DHVI) has initiated enrollment of volunteers for a clinical
June 2, 2023
News Items
Dr. Florian Krammer Elected as a Fellow into the American Academy of Microbiology
Florian Krammer, Principal Investigator of SEM-CIVIC, was elected to the 2023 Fellowship Class for the American Academy of Microbiology for his significant contributions to the field of microbiology.
March 24, 2023
News Items
Dr. Kristy Ainslie Presented with the 2023 Sato Memorial International Award
The Pharmaceutical Society of Japan awarded Dr. Kristy Ainslie, of CIVR-HRP, the 2023 Sato Memorial International Award for her notable achievements in the field of pharmaceutical sciences.
March 24, 2023
News Items
A Multivalent mRNA Influenza Vaccine for Broad Immunity to Seasonal and Pandemic Influenza in Animal Models
Researchers from Duke CIVIC Vaccine Center (DCVC) developed an mRNA-lipid nanoparticle vaccine incorporating hemagglutinin antigens from 20 different influenza subtypes.
February 3, 2023
PI’s Perspective: An Introduction to the Duke CIVICs Clinical Core
We interviewed the Principal Investigators responsible for leading each of the CIVICs Centers as part of a two-part interview series. Previously, we learned about the
November 23, 2022
News Items
Duke CIVICs Clinical Core PI Profile: Chip Walter
CIVICs | Duke CIVICs Clinical Core | Principal Investigator Profile We interviewed the Principal Investigators (PIs) responsible for leading each of the CIVICs Centers as
November 22, 2022
FluGen Announces Completion of First Pediatric Cohort in Clinical Trial of M2SR Influenza Vaccine
The National Institute of Allergy and Infectious Diseases (NIAID) Collaborative Influenza Vaccine Innovation Centers (CIVICs) program is addressing critical gaps in the prevention and control of influenza
September 23, 2022